Clinical Trial

Cardiometabolic Disease and Substrate Metabolism

Name: Cardiometabolic Disease and Substrate Metabolism — clinical trial record (NCT07565727)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CAP

Recruiting

View on ClinicalTrials.gov →

Summary

This study's primary purpose is to determine the potential relationship between cardiometabolic disease, specifically insulin resistance (HOMA-IR), and maternal lipid oxidation.

Trial Details

NCT Number	NCT07565727
Lead Sponsor	University of Tennessee Graduate School of Medicine
Conditions	Preeclampsia, Gestational Diabetes Mellitus (GDM), Preeclampsia (PE), Preeclampsia (PE) Risk, Gestational Diabetes, Gestational Diabetes Mellitus in Pregnancy, Cardiometabolic Diseases, Insulin Resistance +4 more
Enrollment	50 participants
Start Date	2025-12-10
Primary Completion	2026-08 (estimated)
Study Completion	2027-08 (estimated)
Updated on ClinicalTrials.gov	2026-05-04